Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Early intervention is critical at the time of managing these potentially dangerous complications
Bottom line: B12 is essential for our health at all ages
A new Alzheimer's disease interventive strategy: GLP-1
I n December 2024, Torrent Pharma acquired three diabetes brands from Boehringer Ingelheim, including those with Empagliflozin, to strengthen its anti-diabetes portfolio In November 2024, AstraZeneca presented promising early data for its obesity pipeline, including AZD5004, an oral GLP-1 receptor blocker, at Obesity Week 2024
Lyxumia (lixisenatide) EPAR Product Information
D- L-
US$ 27.06
US$ 21.68
US$ 22.41
US$ 28.63
US$ 27.17
